Form 425 - Prospectuses and communications, business combinations:
SEC Accession No. 0000950170-24-051410
Filing Date
2024-05-01
Accepted
2024-05-01 17:27:18
Documents
3

Document Format Files

Seq Description Document Type Size
1 425 aktx_425_8-k_04.25.24.htm 425 50465
2 EX-10.1 aktx-ex10_1.htm EX-10.1 17260
3 EX-99.1 aktx-ex99_1.htm EX-99.1 42078
  Complete submission text file 0000950170-24-051410.txt   111817
Mailing Address 22 BOSTON WHARF ROAD FL 7 BOSTON MA 02210
Business Address 22 BOSTON WHARF ROAD FL 7 BOSTON MA 02210 (646) 350-0702
Akari Therapeutics Plc (Filed by) CIK: 0001541157 (see all company filings)

EIN.: 981034922 | State of Incorp.: X0
Type: 425
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address 22 BOSTON WHARF ROAD FL 7 BOSTON MA 02210
Business Address 22 BOSTON WHARF ROAD FL 7 BOSTON MA 02210 (646) 350-0702
Akari Therapeutics Plc (Subject) CIK: 0001541157 (see all company filings)

EIN.: 981034922 | State of Incorp.: X0
Type: 425 | Act: 34 | File No.: 001-36288 | Film No.: 24904230
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)